Can Fite Biofarma Stock (AMEX: CANF) stock price, news, charts, stock research, profile.
You can purchase shares of Can Fite Biofarma (AMEX:CANF) through any online brokerage.
Other companies in Can Fite Biofarma’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Galecto (NASDAQ:GLTO), Alzamend Neuro (NASDAQ:ALZN), Dermata Therapeutics (NASDAQ:DRMA) and T2 Biosystems (NASDAQ:TTOO).
Can Fite Biofarma has a consensus price target of $12.67.
The stock price for Can Fite Biofarma (AMEX: CANF) is $1.42 last updated February 6, 2025 at 5:46 PM EST.
There are no upcoming dividends for Can Fite Biofarma.
Can Fite Biofarma’s FY earnings are confirmed for Tuesday, February 18, 2025.
There is no upcoming split for Can Fite Biofarma.
Can Fite Biofarma is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.